Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase EARLY_PHASE1 1Phase 1/2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Glioblastoma 82Glioma 66Brain Neoplasms 60Neuroblastoma 14Astrocytoma 14Neoplasms 10Medulloblastoma 9Oligodendroglioma 8Gliosarcoma 8Breast Neoplasms 8Meningioma 7Diffuse Intrinsic Pontine Glioma 7Central Nervous System Neoplasms 7Sarcoma 6Recurrence 6Neoplasm Metastasis 6Melanoma 6Lung Neoplasms 6Ependymoma 6Osteosarcoma 4Neuroma, Acoustic 4Lymphoma, Follicular 4Squamous Cell Carcinoma of Head and Neck 3Rhabdoid Tumor 3Prostatic Neoplasms 3Pheochromocytoma 3Pancreatic Neoplasms 3Ovarian Neoplasms 3Neurofibromatosis 2 3Lymphoma 3

Interventions

atezolizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Adenoviridae Infections × CNS × Clear all
NCT07538128 2026-04-20

Evaluating Safety, Tolerability, and Preliminary Efficacy of YSCH-01 Monotherapy and in Combination With Atezolizumab for Recurrent Glioblastoma

Huashan Hospital

Phase EARLY_PHASE1 Recruiting
10 enrolled
CNS

Adenoviridae Infections, Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡